Oculis and EURETINA Announce the 2025 Ramin Tadayoni Award
ZUG, Switzerland, April 17, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq:…
Tonix Pharmaceuticals Announces Oral Presentation and Panel Participation at the World Vaccine Congress Washington 2025
April 16, 2025 07:00 ET | Source: Tonix Pharmaceuticals Holding Corp. CHATHAM,…
DBV Technologies announces filing of 2024 Annual Report on Form 10-K and Universal Registration Document
Châtillon, France, April 11, 2025 DBV Technologies announces filing of 2024 Annual…
Theratechnologies Responds to Future Paks Press Release and Announces Exclusive Discussions with Another Potential Acquiror for the Sale of the Company
April 11, 2025 17:00 ET | Source: Theratechnologies MONTREAL, April 11, 2025…
First Patient Enrolled in NIH-Funded Expanded Access Program (EAP) Trial to Evaluate MN-166 in Amyotrophic Lateral Sclerosis (ALS) Patients
April 08, 2025 19:00 ET | Source: MediciNova, Inc. LA JOLLA, Calif.,…
Rhythm Pharmaceuticals to Announce Topline Results from Pivotal Phase 3 TRANSCEND Trial Evaluating Setmelanotide in Patients withAcquired Hypothalamic Obesity
Company to host conference call on April 7 at 8 a.m. ET…
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
WESTLAKE VILLAGE, Calif., April 04, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq:…
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
April 04, 2025 16:05 ET | Source: Syndax Pharmaceuticals, Inc. NEW YORK,…
Greenwich LifeSciences Announces Positive Immune Response Data from FLAMINGO-01 Phase III Clinical Trial
STAFFORD, Texas, April 02, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq:…
Liquidia Corporation to Present at the 24th Annual Needham Virtual Healthcare Conference
MORRISVILLE, N.C., April 01, 2025 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA),…